Cargando…

Bacteria and cells as alternative nano-carriers for biomedical applications

INTRODUCTION: Nano-based systems have received a lot of attention owing to their particular properties and, hence, have been proposed for a wide variety of biomedical applications. These nanosystems could be potentially employed for diagnosis and therapy of different medical issues. Although these n...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Álvarez, Rafaela, Vallet-Regí, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802895/
https://www.ncbi.nlm.nih.gov/pubmed/35076351
http://dx.doi.org/10.1080/17425247.2022.2029844
_version_ 1784642767596552192
author García-Álvarez, Rafaela
Vallet-Regí, María
author_facet García-Álvarez, Rafaela
Vallet-Regí, María
author_sort García-Álvarez, Rafaela
collection PubMed
description INTRODUCTION: Nano-based systems have received a lot of attention owing to their particular properties and, hence, have been proposed for a wide variety of biomedical applications. These nanosystems could be potentially employed for diagnosis and therapy of different medical issues. Although these nanomaterials are designed for specific tasks, interactions, and transformations when administered to the human body affect their performance and behavior. In this regard, bacteria and other cells have been presented as alternative nanocarriers. These microorganisms can be genetically modified and customized for a more specific therapeutic action and, in combination with nanomaterials, can lead to bio-hybrids with a unique potential for biomedical purposes. AREAS COVERED: Literature regarding bacteria and cells employed in combination with nanomaterials for biomedical applications is revised and discussed in this review. The potential as well as the limitations of these novel bio-hybrid systems are evaluated. Several examples are presented to show the performance of these alternative nanocarriers. EXPERT OPINION: Bio-hybrid systems have shown their potential as alternative nanocarriers as they contribute to better performance than traditional nano-based systems. Nevertheless, their limitations must be studied, and advantages and drawbacks assessed before their application to medicine.
format Online
Article
Text
id pubmed-8802895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88028952022-02-01 Bacteria and cells as alternative nano-carriers for biomedical applications García-Álvarez, Rafaela Vallet-Regí, María Expert Opin Drug Deliv Review INTRODUCTION: Nano-based systems have received a lot of attention owing to their particular properties and, hence, have been proposed for a wide variety of biomedical applications. These nanosystems could be potentially employed for diagnosis and therapy of different medical issues. Although these nanomaterials are designed for specific tasks, interactions, and transformations when administered to the human body affect their performance and behavior. In this regard, bacteria and other cells have been presented as alternative nanocarriers. These microorganisms can be genetically modified and customized for a more specific therapeutic action and, in combination with nanomaterials, can lead to bio-hybrids with a unique potential for biomedical purposes. AREAS COVERED: Literature regarding bacteria and cells employed in combination with nanomaterials for biomedical applications is revised and discussed in this review. The potential as well as the limitations of these novel bio-hybrid systems are evaluated. Several examples are presented to show the performance of these alternative nanocarriers. EXPERT OPINION: Bio-hybrid systems have shown their potential as alternative nanocarriers as they contribute to better performance than traditional nano-based systems. Nevertheless, their limitations must be studied, and advantages and drawbacks assessed before their application to medicine. Taylor & Francis 2022-01-25 /pmc/articles/PMC8802895/ /pubmed/35076351 http://dx.doi.org/10.1080/17425247.2022.2029844 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Review
García-Álvarez, Rafaela
Vallet-Regí, María
Bacteria and cells as alternative nano-carriers for biomedical applications
title Bacteria and cells as alternative nano-carriers for biomedical applications
title_full Bacteria and cells as alternative nano-carriers for biomedical applications
title_fullStr Bacteria and cells as alternative nano-carriers for biomedical applications
title_full_unstemmed Bacteria and cells as alternative nano-carriers for biomedical applications
title_short Bacteria and cells as alternative nano-carriers for biomedical applications
title_sort bacteria and cells as alternative nano-carriers for biomedical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802895/
https://www.ncbi.nlm.nih.gov/pubmed/35076351
http://dx.doi.org/10.1080/17425247.2022.2029844
work_keys_str_mv AT garciaalvarezrafaela bacteriaandcellsasalternativenanocarriersforbiomedicalapplications
AT valletregimaria bacteriaandcellsasalternativenanocarriersforbiomedicalapplications